Altered function of nitrergic nerves inhibiting sympathetic neurotransmission in mesenteric vascular beds of renovascular hypertensive rats

Hypertension Research

Volumn 33, Issue 5, 2010, Pages 485-491

  Koyama, Toshihiro ^a   Hatanaka, Yukako ^a   Jin, Xin ^a   Yokomizo, Ayako ^a   Fujiwara, Hidetoshi ^a   Goda, Mitsuhiro ^a   Hobara, Narumi ^b   Zamami, Yoshito ^a   Kitamura, Yoshihisa ^a   Kawasaki, Hiromu ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Adrenergic neurotransmission; Neuronal nitric oxide; Nitrergic nerve innervation; Rat mesenteric artery; Renovascular hypertension

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NORADRENALIN;

ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HEART RATE; IMMUNOHISTOCHEMISTRY; MALE; MESENTERIC ARTERY; MESENTERY BLOOD FLOW; NERVE STIMULATION; NITRERGIC NERVE; NONHUMAN; NORADRENALIN RELEASE; PERFUSION PRESSURE; PROTEIN EXPRESSION; RAT; RENOVASCULAR HYPERTENSION; SYSTOLIC BLOOD PRESSURE; VASOCONSTRICTION; VASODILATATION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; HYPERTENSION, RENAL; IMMUNOHISTOCHEMISTRY; MALE; MESENTERIC ARTERIES; MICROSCOPY, CONFOCAL; NG-NITROARGININE METHYL ESTER; NITRERGIC NEURONS; NITRIC OXIDE SYNTHASE TYPE I; NOREPINEPHRINE; RATS; RATS, WISTAR; SYMPATHETIC NERVOUS SYSTEM; SYNAPTIC TRANSMISSION;

EID: 77951954835     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2010.48     Document Type: Article

References (36)

1. Kawasaki H, Takasaki K, Saito A, Goto K. Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat. Nature 1988; 335: 164-167.
2. Toda N, Okamura T. Mechanism of neurally induced monkey mesenteric artery relaxation and contraction. Hypertension 1992; 19: 161-166.
3. Macarthur H, Westfall TC, Wilken GH. Oxidative stress attenuates NO-induced modulation of sympathetic neurotransmission in the mesenteric arterial bed of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2008; 294: H183-H189.
4. Shiraki H, Kawasaki H, Tezuka S, Nakatsuma A, Kurosaki Y. Endogenous calcitonin gene-related peptide (CGRP) mediates adrenergic-dependent vasodilation induced by nicotine in mesenteric resistance arteries of the rat. Br J Pharmacol 2000; 130: 1083-1091.
5. Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990; 347: 768-770.
6. Hatanaka Y, Hobara N, Honghua J, Akiyama S, Nawa H, Kobayashi Y, Takayama F, Gomita Y, Kawasaki H. Neuronal nitric-oxide synthase inhibition facilitates adrenergic neurotransmission in rat mesenteric resistance arteries. J Pharmacol Exp Ther 2006; 316: 490-497.
7. Toda N, Okamura T. Nitroxidergic nerve: regulation of vascular tone and blood flow in the brain. J Hypertens 1996; 14: 423-434.
8. Breslow MJ, Tobin JR, Bredt DS, Ferris CD, Snyder SH, Traystman RJ. Role of nitric oxide in adrenal medullary vasodilation during catecholamine secretion. Eur J Pharmacol 1992; 210: 105-106.
9. Yamamoto R, Wada A, Asada Y, Yuhi T, Yanagita T, Niina H, Sumiyoshi A. Functional relation between nitric oxide and noradrenaline for the modulation of vascular tone in rat mesenteric vasculature. Naunyn Schmiedebergs Arch Pharmacol 1994; 349: 362-366.
10. Vo PA, Reid JJ, Rand MJ. Endothelial nitric oxide attenuates vasoconstrictor responses to nerve stimulation and noradrenaline in the rat tail artery. Eur J Pharmacol 1991; 199: 123-125.
11. Woodman OL, Pannangpetch P. Enhancement of noradrenergic constriction of large coronary arteries by inhibition of nitric oxide synthesis in anaesthetized dogs. Br J Pharmacol 1994; 112: 443-448.
12. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension 1989; 14: 177-183.
13. Esler M, Ferrier C, Lambert G, Eisenhofer G, Cox H, Jennings G. Biochemical evidence of sympathetic hyperactivity in human hypertension. Hypertension 1991; 17: III29-III35.
14. Westfall TC, Meldrum MJ. Alterations in the release of norepinephrine at the vascular neuroeffector junction in hypertension. Annu Rev Pharmacol Toxicol 1985; 25: 621-641.
15. Katholi RE, Whitlow PL, Winternitz SR, Oparil S. Importance of the renal nerves in established two-kidney, one clip Goldblatt hypertension. Hypertension 1982; 4: 166-174.
16. Fujita M, Ando K, Nagae A, Fujita T. Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in salt-sensitive hypertension. Hypertension 2007; 50: 360-367.
17. Tsuda K, Kuchii M, Nishio I, Masuyama Y. Neurotransmitter release, vascular responsiveness and their suppression by Ca-antagonist in perfused mesenteric vasculature of DOCA-salt hypertensive rats. Clin Exp Hypertens A 1986; 8: 259-275. (Pubitemid 16078845)
18. Kawasaki H, Nuki C, Saito A, Takasaki K. Role of calcitonin gene-related peptide-containing nerves in the vascular adrenergic neurotransmission. J Pharmacol Exp Ther 1990; 252: 403-409.
19. Takenaga M, Kawasaki H. Endogenous calcitonin gene-related peptide suppresses vasoconstriction mediated by adrenergic nerves in rat mesenteric resistance blood vessels. Eur J Pharmacol 1999; 367: 239-245.
20. Hobara N, Gessei-Tsutsumi N, Goda M, Takayama F, Akiyama S, Kurosaki Y, Kawasaki H. Long-term inhibition of angiotensin prevents reduction of periarterial innervation of calcitonin gene-related peptide (CGRP)-containing nerves in spontaneously hypertensive rats. Hypertens Res 2005; 28: 465-474.
21. Hobara N, Goda M, Kitamura Y, Takayama F, Kawasaki H. Innervation and functional changes in mesenteric perivascular calcitonin gene-related peptide-and neuropeptide Y-containing nerves following topical phenol treatment. Neuroscience 2006; 141: 1087-1099.
22. Kawasaki H, Takasaki K. Vasoconstrictor response induced by 5-hydroxytryptamine released from vascular adrenergic nerves by periarterial nerve stimulation. J Pharmacol Exp Ther 1984; 229: 816-822.
23. Kawasaki H, Urabe M, Takasaki K. Enhanced 5-hydroxytryptamine release from vascular adrenergic nerves in spontaneously hypertensive rats. Hypertension 1987; 10: 321-327.
24. Eikenburg DC, Lokhandwala MF. Effects of captopril on vascular noradrenergic transmission during the development of two-kidney, one clip Goldblatt hypertension in rats. J Hypertens 1983; 1: 115-122.
25. Draper AJ, Meghji S, Redfern PH. Enhanced presynaptic facilitation of vascular adrenergic neurotransmission in spontaneously hypertensive rats. J Auton Pharmacol 1989; 9: 103-111.
26. Kolo LL, Westfall TC, Macarthur H. Nitric oxide decreases the biological activity of norepinephrine resulting in altered vascular tone in the rat mesenteric arterial bed. Am J Physiol Heart Circ Physiol 2004; 286: H296-H303.
27. Kolo LL, Westfall TC, Macarthur H. Modulation of neurotransmitter release by NO is altered in mesenteric arterial bed of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2004; 287: H1842-H1847.
28. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74: 1141-1148.
29. Zalba G, San Jose G, Moreno MU, Fortuno MA, Fortuno A, Beaumont FJ, Diez J. Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension 2001; 38: 1395-1399.
30. Nava E, Farre AL, Moreno C, Casado S, Moreau P, Cosentino F, Luscher TF. Alterations to the nitric oxide pathway in the spontaneously hypertensive rat. J Hypertens 1998; 16: 609-615.
31. Qadri F, Arens T, Schwartz EC, Hauser W, Dominiak P. Angiotensin- converting enzyme inhibitors and AT1-receptor antagonist restore nitric oxide synthase (NOS) activity and neuronal NOS expression in the adrenal glands of spontaneously hypertensive rats. Jpn J Pharmacol 2001; 85: 365-369.
32. Ruetten H, Zabel U, Linz W, Schmidt HH. Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats. Circ Res 1999; 85: 534-541.
33. Heaton DA, Lei M, Li D, Golding S, Dawson TA, Mohan RM, Paterson DJ. Remodeling of the cardiac pacemaker L-type calcium current and its beta-adrenergic responsiveness in hypertension after neuronal NO synthase gene transfer. Hypertension 2006; 48: 443-452.
34. Kawasaki H, Cline Jr WH, Su C. Enhanced angiotensin-mediated facilitation of adrenergic neurotransmission in spontaneously hypertensive rats. J Pharmacol Exp Ther 1982; 221: 112-116. (Pubitemid 12156480)
35. Dworakowski R, Alom-Ruiz SP, Shah AM. NADPH oxidase-derived reactive oxygen species in the regulation of endothelial phenotype. Pharmacol Rep 2008; 60: 21-28.
36. Li D, Wang L, Lee CW, Dawson TA, Paterson DJ. Noradrenergic cell specific gene transfer with neuronal nitric oxide synthase reduces cardiac sympathetic neurotrans-mission in hypertensive rats. Hypertension 2007; 50: 69-74.